This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MFG or BMA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MFG vs. BMA: Which Stock Is the Better Value Option?
Are Options Traders Betting on a Big Move in Macro Bank Stock?
by Zacks Equity Research
Investors need to pay close attention to BMA stock based on the movements in the options market lately.
BMA vs. ITUB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BMA vs. ITUB: Which Stock Is the Better Value Option?
Is Macro Bank (BMA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Banco Macro (BMA) Loses 15.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Banco Macro (BMA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BMA or ITUB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BMA vs. ITUB: Which Stock Is the Better Value Option?
Is the Options Market Predicting a Spike in Macro Bank Stock?
by Zacks Equity Research
Investors need to pay close attention to BMA stock based on the movements in the options market lately.
BMA vs. ITUB: Which Stock Is the Better Value Option?
by Zacks Equity Research
BMA vs. ITUB: Which Stock Is the Better Value Option?
Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Banco Macro (BMA)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Banco Macro (BMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Company News for May 30, 2025
by Zacks Equity Research
Companies in The News Are: A, VEEV, HPQ, BMA